Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial

Junichi Koike, Shingo Kameoka, Kazuhiro Sakamoto et al.|Cancer Chemotherapy and Pharmacology|2017

Cited by 50